3 Results for "

NT2

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "NT2" in MCE Product Catalog:

  • Targets Recommended:
1
1 Cited Publications
Cat. No.: HY-124767
CAS No.: 184162-21-8
Purity:  98.90%
Research Areas:  

Neurological Disease

SR 142948A is a non-peptide neuropeptide neuropeptin (NT) receptor antagonist. SR 142948A is able to bind to neuropeptin receptors, especially with high affinity for NT1 and NT2 receptors. SR 142948A is mainly used to study the role of neuropeptide in the neurotransmitter system, especially the dopamine system .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-155612A
CAS No.: 2649883-37-2
Purity:  99.75%
Target:  

Caspase

Research Areas:  

Neurological Disease

(Rac)-M826 is the racemate of M826 (HY-155612). M826 is a selective and reversible inhibitor for caspase-3 with an IC50 of 0.005 μM. M826 inhibits apoptosis in cell NT2. M826 can be used for nervous system diseases research .
loading...
    loading...
Cat. No.: HY-112363
CAS No.: 496864-16-5
Synonyms: RP107
Target:  

CDK GSK-3 ERK JNK CFTR

Research Areas:  

Inflammation/Immunology Cancer

Aloisine A (RP107) is a a potent cyclin-dependent kinase (CDK) inhibitor with IC50s of 0.15 μM, 0.12 μM, 0.4 μM, 0.16 μM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK5/p35, respectively. Aloisine A ininhibits GSK-3α (IC50=0.5 μM) and GSK-3β (IC50=1.5 μM). Aloisine A stimulates wild-type CFTR and mutated CFTR, with submicromolar affinity by a cAMP-independent mechanism. Aloisine A has the potential for CFTR-related diseases, including cystic fibrosis research [2].
loading...
    loading...